Study of 0.1% Uracil Topical Cream (UTC) for the Prevention of Hand-Foot Syndrome
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Palmar-Plantar Erythrodysesthesia|Breast Cancer
Interventions: DRUG: Cream|DRUG: 0.1% Uracil Cream
Sponsor: Nanometics (d.b.a. PHD Biosciences)